Conclusions: Our study indicated that KIFC1 harbors the potential to be a prognostic and immunotherapeutic biomarker of tumors, and it can have an impact on the metastasis and the cell cycle of pancreatic cancer cells. The gene discussed is KIFC1; the disease is familial pancreatic carcinoma.